112 related articles for article (PubMed ID: 2981523)
1. Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
Nichols RL; Smith JW; Adinolfi MF; Galli R; Vivoda LM
Arch Surg; 1985 Jan; 120(1):36-42. PubMed ID: 2981523
[TBL] [Abstract][Full Text] [Related]
2. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
Stromberg BV; Reines HD; Hunt P
Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
[TBL] [Abstract][Full Text] [Related]
4. A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections.
Mehtar S; Croft RJ; Hilas A
J Antimicrob Chemother; 1986 Mar; 17(3):389-96. PubMed ID: 3009384
[TBL] [Abstract][Full Text] [Related]
5. Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
Plouffe JF
Antimicrob Agents Chemother; 1982 Mar; 21(3):519-20. PubMed ID: 6285812
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
Chao HP; Ho SW; Luh KT; Hsieh WC
Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
[No Abstract] [Full Text] [Related]
7. Microbiological properties of sulbactam combined with ampicillin.
Barba D; Galante D; Esposito S; Ruffilli MP
Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
[TBL] [Abstract][Full Text] [Related]
8. Worldwide clinical experience with sultamicillin.
Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
[TBL] [Abstract][Full Text] [Related]
9. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
Lees L; Milson JA; Knirsch AK; Greenhalgh K
Rev Infect Dis; 1986; 8 Suppl 5():S644-50. PubMed ID: 3026019
[TBL] [Abstract][Full Text] [Related]
10. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
Wald E; Reilly JS; Bluestone CD; Chiponis D
Rev Infect Dis; 1986; 8 Suppl 5():S617-9. PubMed ID: 3026014
[TBL] [Abstract][Full Text] [Related]
11. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.
Löffler L; Bauernfeind A; Keyl W
Drugs; 1988; 35 Suppl 7():46-52. PubMed ID: 3265378
[TBL] [Abstract][Full Text] [Related]
12. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
[TBL] [Abstract][Full Text] [Related]
13. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Campoli-Richards DM; Brogden RN
Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
Galante D; Esposito S; Barba D; Ruffilli MP
J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
[TBL] [Abstract][Full Text] [Related]
15. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
[TBL] [Abstract][Full Text] [Related]
16. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
Hemsell DL
Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ampicillin-resistant acute otitis media in the chinchilla.
Reilly JS; Doyle WJ; Cantekin EI; Supance JS; Kim HK; Rohn DD; Bluestone CD
Arch Otolaryngol; 1983 Aug; 109(8):533-5. PubMed ID: 6307238
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance of Staphylococcus aureus isolates from community acquired soft tissue infections in Bulawayo.
Oliver MJ; Macheka A; Watson N
Cent Afr J Med; 1989 Feb; 35(2):327-9. PubMed ID: 2776198
[TBL] [Abstract][Full Text] [Related]
19. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
Löffler L; Bauernfeind A; Keyl W; Hoffstedt B; Piergies A; Lenz W
Rev Infect Dis; 1986; 8 Suppl 5():S593-8. PubMed ID: 3026009
[TBL] [Abstract][Full Text] [Related]
20. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
